Dr. Paul S. Bradley, MD As Scripta’s Chief Medical Officer and an actively practicing clinician currently participating in GLP-1 clinical trials, I’ve had a front-row seat to one of the most significant shifts in obesity medicine in decades.
Need help?
Contact usDr. Paul S. Bradley, MD As Scripta’s Chief Medical Officer and an actively practicing clinician currently participating in GLP-1 clinical trials, I’ve had a front-row seat to one of the most significant shifts in obesity medicine in decades.